Detalhe da pesquisa
1.
Molecular mechanisms associated with chemoresistance in esophageal cancer.
Cell Mol Life Sci
; 79(2): 116, 2022 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113247
2.
Interplay between HMGA and TP53 in cell cycle control along tumor progression.
Cell Mol Life Sci
; 78(3): 817-831, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920697
3.
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
Cancer
; 127(18): 3413-3421, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181755
4.
Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer.
Am J Gastroenterol
; 116(9): 1859-1867, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313623
5.
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
Blood
; 133(2): 156-167, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455381
6.
High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma.
Blood
; 133(11): 1217-1221, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30692124
7.
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies.
Haematologica
; 106(4): 1079-1085, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107329
8.
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
Ann Hematol
; 100(9): 2325-2337, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33970288
9.
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Lancet
; 393(10168): 253-264, 2019 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545780
10.
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials.
Haematologica
; 105(4): 1074-1080, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248973
11.
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial.
Haematologica
; 105(7): 1937-1947, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582542
12.
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.
Cancer
; 125(5): 750-760, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561775
13.
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 375(8): 754-66, 2016 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557302
14.
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 374(17): 1621-34, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119237
15.
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.
Blood
; 130(24): 2610-2618, 2017 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054911
16.
Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies.
Haematologica
; 104(8): 1640-1647, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733270
17.
Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial.
Haematologica
; 104(11): 2265-2273, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948492
18.
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.
N Engl J Med
; 373(13): 1207-19, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308596
19.
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
N Engl J Med
; 373(7): 621-31, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26035255
20.
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.
N Engl J Med
; 372(2): 142-52, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25482145